Drug-eluting devices gain more acceptance in India; Sumavel DosePro wins innovation award;

> Use of drug-eluting devices for angioplasty is gaining more acceptance in India. Article

> The Sumavel DosePro, a needle-free drug delivery system sold by Zogenix of San Diego has won a "most innovative medical product" award by Connect, a San Diego group that supports technology entrepreneurs. Report

> The FDA may have lost a fight in the courts to regulate e-cigarettes as drug delivery devices, but one county in Washington state is the latest government body to propose a ban. Report

> Drug delivery dissertation of the week: Enhanced anticancer drug delivery using electrical pulses. Abstract

> Drug delivery patent application of the week: Modified Polysaccharide-Based Delivery of Nucleic Acids. Patent application

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.